RenovoRx

RenovoRx (Nasdaq: RNXT) is developing innovative targeted oncology therapies and commercializing RenovoCath®, a novel, FDA-cleared drug-delivery device.

11/07/2025

Reminder: RenovoRx will host its third quarter 2025 financial results and business highlights conference call on Thursday, November 13th at 4:30 p.m. ET. For dial-in and webcast details: https://bit.ly/47aFaH3

11/07/2025

"In my years investigating new approaches to help patients with pancreatic cancer, I have never seen a therapeutic drug-delivery device like that which RenovoRx has developed," commented RenovoRx's new SAB member, Timothy Donahue, MD. Read more: https://bit.ly/43gmByU

11/06/2025

“Dr. Donahue brings deep expertise and prestige in both pancreatic surgery and translational oncology, and we are honored to welcome him to our Scientific Advisory Board,” said Ramtin Agah, MD, Chief Medical Officer and Founder of RenovoRx. https://bit.ly/43gmByU

11/06/2025

RenovoRx today announced the appointment of distinguished UCLA surgeon and pancreatic disease expert, Timothy Donahue, MD, to RenovoRx’s scientific advisory board (SAB). Dr. Donahue will enhance the board’s expertise in surgical oncology and translational oncology research aimed at improving multidisciplinary treatment strategies. Learn more: https://bit.ly/43gmByU

11/05/2025

November is Month! RenovoRx is proud to raise awareness about the urgent need to advance scientific research, share knowledge, and advocate for patients facing this difficult-to-treat cancer. Learn more about our work: https://bit.ly/49zQls2

11/04/2025

RenovoRx CEO, Shaun Bagai, will be participating at the Canaccord Genuity MedTech, Diagnostics & Digital Health & Services Forum, to be held on November 20, 2025. He will share an update on RenovoRx’s commercialization progress, highlight the latest developments from the Company’s ongoing Phase III TIGeR-PaC clinical trial, and discuss the recently launched post-marketing observational registry study. For details, visit: https://bit.ly/3LolmYb

11/03/2025

Tune-in tomorrow, November 4th at 5:00 PM PT, for the TAMP Peer-to-Peer Best Practices Workshop with cases presented by Dr. Ripal Gandhi and Dr. Juan Camacho Vasquez, and followed by a Q&A session. Register for the event here: https://bit.ly/49doAYj

10/28/2025

Join us on Tuesday, November 4th at 5:00 PM PT for the TAMP (Trans-Arterial Micro-Perfusion) Peer-to-Peer Best Practices Workshop, and gain valuable insights into the TAMP therapy platform, enabled by the RenovoCath® device, designed for targeted locoregional therapeutic drug-delivery. Register here: https://bit.ly/49doAYj

10/27/2025

RenovoRx today announced that it will host its third quarter 2025 financial results and business highlights conference call on November 13, 2025, at 4:30 p.m. ET. On the call, RenovoRx’s management is expected to discuss the latest developments and achievements for its ongoing RenovoCath® device commercialization efforts, as well as for the Phase III TIGeR-PaC trial in locally advanced pancreatic cancer and the PanTheR Post-Marketing Registry Study. For more details, visit: https://bit.ly/42Uh4hm

10/23/2025

RenovoRx Chief Clinical Officer, Leesa Gentry, will be a speaker at taking place October 26th - 28th, 2025 in Atlanta, GA. The event brings together industry leaders to discuss innovations that are shaping the future of clinical research, learn more: https://bit.ly/4nmpwNN

10/21/2025

RenovoRx will host the TAMP (Trans-Arterial Micro-Perfusion) Peer-to-Peer Best Practices Workshop on Tuesday, November 4th at 5:00 PM PT, with cases presented by Dr. Ripal Gandhi and Dr. Juan Camacho Vasquez. This educational workshop is an interactive peer-to-peer forum designed for physicians to share their experiences, including case presentations, with the TAMP therapy platform, enabled by the RenovoCath® device. Register for the workshop here: https://bit.ly/49doAYj

10/17/2025

Dr. Ripal Gandhi, interventional radiologist at Miami Cancer Institute, will present during Session 5: "What’s New and Hot: Emerging Therapies and New Technologies" at tomorrow, October 18th. Dr. Gandhi will discuss the latest advances in oncology therapies and highlight RenovoRx’s patented Trans-Arterial Micro-Perfusion (TAMP™) platform, designed for targeted drug-delivery via the RenovoCath® device, while potentially minimizing a therapy’s toxicities versus systemic intravenous therapy. For event details: https://bit.ly/46KJ7Aj

Address

Mountain View, CA

Website

http://www.renovorx.com/

Alerts

Be the first to know and let us send you an email when RenovoRx posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to RenovoRx:

Shortcuts

Want your practice to be the top-listed Clinic in Mountain View?

11/07/2025

11/07/2025

11/06/2025

11/06/2025

11/05/2025

11/04/2025

11/03/2025

10/28/2025

10/27/2025

10/23/2025

10/21/2025

10/17/2025

Address

Website

Alerts

Contact The Practice

Shortcuts

Share